$177.54 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Medpace

Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

Stock Analysis

last close $183.05
1-mo return 11.2%
3-mo return 11.9%
avg daily vol. 127.02T
52-week high 196.12
52-week low 85.22
market cap. $6.3B
forward pe 42
annual div. -
roe 20.2%
ltg forecast 13.6%
dividend yield -
annual rev. $955M
inst own. 80.9%

Subscribe now for daily local and international financial news